These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 2267774)

  • 1. [Postvaccinal anti-influenza immunity and its determining factors].
    Kastrikina LN; Lonskaia NI
    Vopr Virusol; 1990; 35(5):362-7. PubMed ID: 2267774
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody responses to inactivated influenza vaccines and partial protective effect of anti-neuraminidase antibody against epidemics of A(H3N2) and A(H1N1) influenza.
    Maeda A; Oishi I; Minekawa Y; Kunita N; Funahashi S; Yagura H
    Biken J; 1979 Sep; 22(3):91-8. PubMed ID: 533537
    [No Abstract]   [Full Text] [Related]  

  • 3. [Basic characteristics of a live influenza vaccine for children from type A influenza (H1N1 and H3N2) used separately and in combination].
    Rudenko LG; Shvartsman IaS; Ispolatova AV; Grigor'eva EP; Drinevskiĭ VP
    Vopr Virusol; 1989; 34(1):29-34. PubMed ID: 2728404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The systemic and mucosal immune response of humans to influenza A virus.
    Murphy BR; Clements ML
    Curr Top Microbiol Immunol; 1989; 146():107-16. PubMed ID: 2659262
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection.
    Monto AS; Petrie JG; Cross RT; Johnson E; Liu M; Zhong W; Levine M; Katz JM; Ohmit SE
    J Infect Dis; 2015 Oct; 212(8):1191-9. PubMed ID: 25858957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristic of humoral response of elderly to inactivated influenza vaccine.
    Siennicka J
    Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):389-94. PubMed ID: 9017157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variant-specific antihemagglutinin serum response to type A influenza natural infection and inactivated vaccines in adults.
    Kasel JA; Six HR; Couch RB; Greenberg SB; Cate TR
    Proc Soc Exp Biol Med; 1979 Sep; 161(4):519-21. PubMed ID: 90369
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccination of an adolescent group with A (H3N2) + A(HSW1N1) bivaccine before an A (H1N1) influenza epidemic.
    Stumpa A; Cihla F; Tůmová B; Husek V; Slezácek J
    Acta Virol; 1979 Sep; 23(5):443-5. PubMed ID: 42307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness of inactivated vaccines against influenza].
    Fridman EA; Peradze TV
    Tr Inst Im Pastera; 1982; 58():84-94. PubMed ID: 6764983
    [No Abstract]   [Full Text] [Related]  

  • 10. [The formation of an immune response in volunteers inoculated with a live recombinant influenza vaccine].
    Vorob'ev KV; Rudenko LG; Islamova IT; Grigor'eva EP; Egorov AIu; Ermachenko TA; Chepik EB; Zakharova NG; Karachentsev AM
    Vopr Virusol; 1991; 36(6):475-7. PubMed ID: 1785182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibody functional activity in immunization with influenza vaccines].
    Naĭkhin AN; Artem'eva SA; Ermachenko TA; Vybornykh EN; Kustikova IuG; Doroshenko EV; Katorgina LG; Denisov GM; Kim TN
    Vopr Virusol; 1993; 38(5):204-7. PubMed ID: 8284916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antineuraminidase serum antibodies in natural influenza A and immunization with influenza vaccines].
    Naĭkhin AN; Tsaritsyna IM; Syrodoeva LG; Oleĭnikova EV; Gorev NE
    Vopr Virusol; 1983; (2):154-9. PubMed ID: 6868553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunogenic activity of the viral hemagglutinin and neuraminidase from live and inactivated influenza vaccines].
    Kustikova IuG; Gagarinova VM; Gorev NE; Shadrin AS
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Apr; (4):79-84. PubMed ID: 6868890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on anti-neuraminidase antibody response in serum after inoculation of influenza hemagglutinin vaccines].
    Hiromatsu Y; Sato Y; Inoguchi T; Umeno H; Kurosawa Y; Ishii K; Kobayashi K; Kaji M; Shingu T; Hayashida K
    Kansenshogaku Zasshi; 1984 May; 58(5):367-75. PubMed ID: 6434660
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative long-term effects in a mouse model system of influenza whole virus and purified neuraminidase vaccines followed by sequential infections.
    Johansson BE; Kilbourne ED
    J Infect Dis; 1990 Oct; 162(4):800-9. PubMed ID: 2401790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza A (H3N2) component of recommended vaccine induces antibody to current virus.
    Zuckerman M; Oxford J; Wood J; Taylor J
    Lancet; 1990 Jan; 335(8682):179-80. PubMed ID: 1967480
    [No Abstract]   [Full Text] [Related]  

  • 17. Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccines.
    Mumford JA; Jessett D; Dunleavy U; Wood J; Hannant D; Sundquist B; Cook RF
    Vaccine; 1994 Jul; 12(9):857-63. PubMed ID: 7975864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees.
    Kilbourne ED; Cerini CP; Khan MW; Mitchell JW; Ogra PL
    J Immunol; 1987 May; 138(9):3010-3. PubMed ID: 3571981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological response to whole, split and subunit influenza vaccines of persons with and without immunological experience towards influenza A/U.S.S.R. 90/77 virus.
    Sarateanu DE; Ehrengut W; Pressler K; Peukert M; Schenk KD
    Comp Immunol Microbiol Infect Dis; 1980; 3(1-2):225-36. PubMed ID: 7471712
    [No Abstract]   [Full Text] [Related]  

  • 20. [Correlation of antineuraminidase antibodies and antihemagglutinins in influenza and following administration of live influenza vaccine].
    Nekliudova LI; Fedorova IuB; Orlova NG
    Vopr Virusol; 1974; (2):173-6. PubMed ID: 4446555
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.